Alec Barclay - Mar 14, 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Operations Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Mar 14, 2022
Transactions value $
-$4,160
Form type
4
Date filed
3/30/2022, 04:00 PM
Previous filing
Feb 28, 2022
Next filing
Apr 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +21.7K +13.65% 180K Mar 14, 2022 Direct F1
transaction TTOO Common Stock Tax liability -$4.16K -11.4K -6.33% $0.36 169K Mar 14, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -21.7K -50% $0.00 21.7K Mar 14, 2022 Common Stock 21.7K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 11,428 shares of common stock were automatically withheld at vesting to cover required tax withholding.
F3 On March 14, 2020 the reporting person was granted 65,000 that vest in three equal annual installments commencing on March 14, 2021.